Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Calcium channel protein complex** is a pentameric or tetrameric assembly comprising a central pore-forming alpha-1 subunit and auxiliary beta, alpha-2-delta, and gamma subunits[1][3][7]. This architecture forms highly regulated transmembrane ion channels controlling calcium influx in response to cellular signals and membrane depolarization, thereby influencing diverse processes such as muscle contraction, neurotransmitter release, hormone secretion, and gene transcription[1][3][6][7]. Calcium channels exist as various subclasses (L-type, N-type, P/Q-type, R-type, T-type) with distinct tissue distribution and pharmacology, and their dysfunction or altered expression is implicated in multiple disease states ranging from cardiac arrhythmias to cancer and neurological disorders[2][6]. Drug targeting often involves channel blockers that modulate their conductance or trafficking[4][6][2].
Inhibition of Ca\(^{2+}\) influx by blocking the pore-forming subunit Modulation of channel gating or trafficking by targeting auxiliary subunits Alteration of cell signaling and contraction
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel protein complex (VGCC).